Company Filing History:
Years Active: 2010-2014
Title: Innovations of Jing-Ru Weng in Antitumor Agents
Introduction
Jing-Ru Weng is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development of antitumor agents. With a total of 3 patents, Weng's work focuses on compounds that have the potential to treat cancer or induce apoptosis in proliferating cells.
Latest Patents
Weng's latest patents include the development of alkyl indole-3-carbinol-derived antitumor agents. These compounds are designed to treat cancer or induce apoptosis in proliferating cells. The compounds are characterized by a specific formula where X is selected from hydroxyl, thiol, and amino; Y is selected from carboxyl and sulfonyl; and R, R, R, and R are selected from hydrogen, lower alkyl, and combinations thereof. Additionally, R, R, and R are selected from hydrogen, halo, nitro, amino, methoxy, and combinations thereof, along with pharmaceutically acceptable salts.
Career Highlights
Jing-Ru Weng is affiliated with The Ohio State University, where he continues to advance his research in the field of cancer treatment. His work has garnered attention for its potential impact on therapeutic strategies against cancer.
Collaborations
Weng collaborates with esteemed colleagues such as Ching-Shih Chen and Dasheng Wang, contributing to a dynamic research environment focused on innovative solutions in medicine.
Conclusion
Jing-Ru Weng's contributions to the development of antitumor agents highlight his commitment to advancing cancer treatment. His innovative research and collaborations position him as a key figure in the field of medical science.